Genetics and the Diagnostic Process
At a Glance
FILS syndrome is usually confirmed when genetic testing finds disease-causing changes in both copies of the POLE gene. Whole-exome sequencing, parental testing, and follow-up studies can clarify uncertain findings and distinguish FILS from other POLE-related conditions.
Confirming a diagnosis of FILS syndrome is a technical process that relies heavily on genetic testing. Because the symptoms—like short stature and a lacy skin pattern—can overlap with many other rare conditions, doctors use advanced tools to look directly at your child’s DNA [1][2].
How FILS is Diagnosed
A common way to diagnose FILS is through whole-exome sequencing (WES), though gene panels or genomes are also used [1]. The test looks for two pathogenic or likely pathogenic changes (variants) in the POLE gene [2]. Exome testing can sometimes miss copy-number or deep-intronic variants, meaning a single finding might require follow-up testing. Furthermore, a “Variant of Uncertain Significance” (VUS) alone does not confirm or exclude FILS.
These diagnostic changes are biallelic, meaning they affect both copies of the POLE gene (one inherited from each parent) [1][2]. To confirm this, doctors ideally perform “parental testing” to ensure that one variant came from the mother and one from the father, a state called being in trans [2].
Biallelic vs. Heterozygous: A Critical Difference
When you look at your child’s genetic report or search for the “POLE” gene online, you may see information about colorectal cancer or polyposis, specifically Polymerase Proofreading-Associated Polyposis (PPAP). It is vital to understand that the biallelic presentation in infants and children is a different clinical situation than the heterozygous POLE-related cancer syndromes [3][4].
| Feature | FILS Syndrome (Biallelic) | PPAP Syndrome (Heterozygous) |
|---|---|---|
| Inheritance | Autosomal Recessive (Two copies) [1] | Autosomal Dominant (One copy) [5] |
| Who is affected? | Infants and children [2] | Adults (typically) [5] |
| Mechanism | Not enough POLE protein or reduced function, altering cell division [3][4] | The protein’s proofreading function is impaired, leading to a high rate of DNA errors [5][6] |
| Key Symptoms | Short stature, skin changes, and immune issues [1] | Increased risk of colon polyps and colorectal cancer [5][7] |
If your child has biallelic variants causing FILS, it means their cells are struggling to produce enough working POLE protein to keep up with growth and the immune system [3]. However, not every heterozygous POLE variant causes PPAP. Because a parent of a child with FILS carries one of these variants, you should seek variant-specific genetic counseling to determine if it has any associated cancer risk for your family.
Ruling Out Overlapping Syndromes
Because FILS is part of a “spectrum” of conditions caused by the POLE gene, a comprehensive genetic workup is necessary to rule out other similar disorders [2]. This includes:
- IMAGe Syndrome: A condition characterized by intrauterine growth restriction, adrenal issues, and bone changes. While it has a different genetic cause (CDKN1C), the symptoms can look very similar to the “IMAGe-like” presentation of some POLE disorders [8][3].
- Three-M Syndrome: Another rare cause of short stature and recognizable facial features [9].
- Cernunnos/XLF Deficiency: A different DNA repair disorder that also presents with immunodeficiency and growth issues [1].
Geneticists assess the specific variants to determine where your child falls on this spectrum. Identifying the exact variants allows your medical team to monitor the right systems—like the immune system or growth hormones—from the very beginning [2].
Common questions in this guide
What genetic test is used to diagnose FILS syndrome?
Why are both parents tested for FILS syndrome?
Can a VUS prove that my child has FILS syndrome?
How is FILS syndrome different from POLE-related polyposis?
Does a parent who carries a POLE variant have cancer risk?
What other conditions may be considered when FILS testing is inconclusive?
One line in your results can change your plan.
A single exome sequencing finding might require follow-up testing before the next step is clear. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Facial dysmorphism-immunodeficiency-livedo-short stature syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Case report: A Chinese boy with facial dysmorphism, immunodeficiency, livedo, and short stature syndrome.
Jiang L, Chen X, Zheng J, et al.
Frontiers in pediatrics 2022; (10()):933108 doi:10.3389/fped.2022.933108.
PMID: 36071887 - 2
Phenotypic continuum between POLE-related recessive disorders: A case report and literature review.
Roberts ME, Nimrichter S, Marshall ML, et al.
American journal of medical genetics. Part A 2022; (188(10)):3121-3125 doi:10.1002/ajmg.a.62908.
PMID: 35860951 - 3
DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency.
Logan CV, Murray JE, Parry DA, et al.
American journal of human genetics 2018; (103(6)):1038-1044 doi:10.1016/j.ajhg.2018.10.024.
PMID: 30503519 - 4
Novel POLE mutations identified in patients with IMAGE-I syndrome cause aberrant subcellular localisation and protein degradation in the nucleus.
Nakano T, Sasahara Y, Kikuchi A, et al.
Journal of medical genetics 2022; doi:10.1136/jmedgenet-2021-108300.
PMID: 35534205 - 5
Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction.
Hamzaoui N, Alarcon F, Leulliot N, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2020; (22(9)):1533-1541 doi:10.1038/s41436-020-0828-z.
PMID: 32424176 - 6
Interpretation of somatic POLE mutations in endometrial carcinoma.
León-Castillo A, Britton H, McConechy MK, et al.
The Journal of pathology 2020; (250(3)):323-335 doi:10.1002/path.5372.
PMID: 31829442 - 7
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.
Buchanan DD, Stewart JR, Clendenning M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(8)):890-895 doi:10.1038/gim.2017.185.
PMID: 29120461 - 8
An Intronic Variant in CDKN1C Gene Causing IMAGe Syndrome in an Iranian Girl.
Dalili S, Hoseini Nouri SA, Sharifi A, et al.
Molecular genetics & genomic medicine 2025; (13(11)):e70154 doi:10.1002/mgg3.70154.
PMID: 41218602 - 9
Typical Face, Developmental Delay, and Hearing Loss in a Patient with 3M Syndrome: The Co-Occurrence of Two Rare Conditions.
Akalın A, Şimşek-Kiper PÖ, Taşkıran E, et al.
Molecular syndromology 2023; (13(6)):537-542 doi:10.1159/000524703.
PMID: 36660029
This page explains FILS syndrome genetic testing for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your child's results and guide testing for your family.